| Literature DB >> 24704690 |
Jianxiu Yao1, Lawrent L Buschman2, Nanyan Lu3, Chitvan Khajuria4, Kun Yan Zhu5.
Abstract
We developed a microarray based on 2895 unique transcripts assembled from 15,000 cDNA sequences from the European corn borer (Ostrinia nubilalis) larval gut. This microarray was used to monitor gene expression in early third-instar larvae of Bacillus thuringiensis (Bt)-susceptible O. nubilalis after 6 h feeding on diet, with or without the Bt Cry1Ab protoxin. We identified 174 transcripts, for which the expression was changed more than two-fold in the gut of the larvae fed Cry1Ab protoxin (p < 0.05), representing 80 down-regulated and 94 up-regulated transcripts. Among 174 differentially expressed transcripts, 13 transcripts putatively encode proteins that are potentially involved in Bt toxicity, and these transcripts include eight serine proteases, three aminopeptidases, one alkaline phosphatase, and one cadherin. The expressions of trypsin-like protease and three aminopeptidase transcripts were variable, but two potential Bt-binding proteins, alkaline phosphatase and cadherin were consistently up-regulated in larvae fed Cry1Ab protoxin. The significantly up and down-regulated transcripts may be involved in Cry1Ab toxicity by activation, degradation, toxin binding, and other related cellular responses. This study is a preliminary survey of Cry1Ab protoxin-induced transcriptional responses in O. nubilalis gut and our results are expected to help with further studies on Bt toxin-insect interactions at the molecular level.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24704690 PMCID: PMC4014733 DOI: 10.3390/toxins6041274
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Figure 1Transcript expression profiles from the gut of O. nubilalis larvae fed Cry1Ab protoxin. The transcriptional responses were compared between the larvae fed a diet containing Cry1Ab protoxin (treatment) and larvae fed a normal diet (control) by using one-way ANOVA (p < 0.05) and the Benjamini-Hochberg multiple testing correction (q < 0.05). Finally, 174 transcripts were identified as differentially expressed based on the cutoff of the fold change (FC) at ≥2.0. The p-value and fold change of each transcript was transformed to negative log and log2 scale, respectively, in the plot. The solid data points represent down-regulated gut transcripts (total 80) and clear data points represent up-regulated transcripts (total 94).
Summary of 119 significantly differentially expressed (fold change ≥2.0 and p < 0.05) transcripts with BLAST results from O. nubilalis larvae in response to the ingestion of Cry1Ab protoxin.
| EST ID | NCBI EST database ID | Gene Homologs | Homolog GenBank Accession No. | Fold Change ± SE * |
|---|---|---|---|---|
|
| ||||
| contig [0243] | GH998064.1 | trypsin precursor | AFM77760.1 | −2.69 ± 0.29 |
| contig [0389] | GH998056.1 | serine protease | AFM77769.1 | 8.39 ± 0.02 |
| contig [0770] | GH997442.1 | trypsin-like serine protease | AFM77762.1 | 3.16 ± 0.14 |
| contig [1207] | GH997507.1 | serine protease | AFM77770.1 | 7.67 ± 0.26 |
| contig [3704] | GH999118.1 | trypsin-like serine protease | AFM77754.1 | 6.36 ± 0.04 |
| contig [4768] | GH998250.1 | trypsin-like serine protease | AFM77753.1 | 10.75 ± 0.12 |
| contig [5740] | GH999046.1 | chymotrypsin-2 (chymotrypsin ii) | AFM77774.1 | 3.26 ± 0.19 |
| ECB-C-18_B11 | GH994018.1 | silk gland derived serine protease | AAR98920.2 | −2.63 ± 0.04 |
| contig [0115] | GH997328.1 | esterase FE4-like ( | XP_004924612.1 | 3.69 ± 0.13 |
| contig [3820] | GH999448.1 | carboxylesterase ( | ADE05548.1 | −2.21 ± 0.12 |
| J-ECB-07_G03 | GH991809.1 | carboxylesterase ( | ACA50924.1 | 3.58 ± 0.06 |
| J-ECB-09_D02 | GH992373.1 | carboxylesterase ( | AEJ38204.1 | −3.31 ± 0.22 |
| ECB-17_F12 | GH998536.1 | carboxylesterase ( | ADD97156.1 | 3.99 ± 0.06 |
| ECB-27_F04 | GH999378.1 | carboxyl/cholinesterase 4A ( | NP_001116814.1 | −2.83 ± 0.11 |
|
| ||||
| J-ECB-25_B09 | GH990771.1 | cadherin-like protein | ACK37450.1 | 2.85 ± 0.20 |
| ECB-V-05_D12 | GH994582.1 | aminopeptidase n3 | AEO12689.1 | −2.55 ± 0.23 |
| contig [4776] | GH998970.1 | aminopeptidase n2 | ACJ64828.1 | 2.17 ± 0.09 |
| contig [4879] | GH997475.1 | aminopeptidase n8 | ACV04931.1 | −2.31 ± 0.12 |
| contig [5858] | GH998639.1 | membrane-bound alkaline phosphatase ( | AEM43806.1 | 2.23 ± 0.06 |
|
| ||||
| contig [0492] | GH998299.1 | caspase-4 ( | AEK20829.1 | 2.36 ± 0.03 |
| ECB-10_C01 | GH997883.1 | pyridoxal kinase ( | NP_001037440.1 | −2.99 ± 0.10 |
| contig [5143] | GH995296.1 | ctl2 antioxidant enzyme ( | XP_001661235.1 | 2.32 ± 0.04 |
|
| ||||
| contig [0814] | GH998546.1 | sodium-bile acid cotransporter ( | EHJ73754.1 | −5.03 ± 0.05 |
| contig [1314] | GH993616.1 | potassium coupled amino acid transporter ( | AAF18560.1 | −4.68 ± 0.16 |
| contig [4763] | GH998142.1 | sodium-bile acid cotransporter ( | XP_001662576.1 | −4.39 ± 0.10 |
| contig [5743] | GH993678.1 | amino acid transporter ( | NP_001124343.1 | −5.40 ± 0.13 |
| ECB-21_C09 | GH998857.1 | sugar transporter ( | EHJ73890.1 | −2.46 ± 0.10 |
| J-ECB-39_E12 | GH992066.1 | sugar transporter ( | XP_001862938.1 | −2.65 ± 0.25 |
| J-ECB-55_E04 | GH988996.1 | monocarboxylate transporter ( | XP_004927805.1 | −3.40 ± 0.10 |
|
| ||||
| contig [3833] | GH993952.1 | DNA-binding nuclear protein p8 ( | ACH56888.1 | 4.89 ± 0.09 |
| contig [4800] | GH998367.1 | endonuclease-reverse transcriptase ( | ADI61826.1 | 2.49 ± 0.04 |
| ECB-V-26_F03 | GH996285.1 | histone H3.2-like ( | XP_003202254.1 | −2.04 ± 0.02 |
| contig [3869] | GH997175.1 | cellular repressor of E1A-stimulated genes 1 ( | XP_972946.1 | −3.16 ± 0.06 |
| contig [5038] | GH991382.1 | MluI cell cycle box (MCB) Binding Factor 2 ( | BAA34219.1 | 2.41 ± 0.11 |
|
| ||||
|
| ||||
| contig [0004] | GH992504.1 | glutathione
| AAF23078.1 | −3.53 ± 0.45 |
| contig [2246] | GH991501.1 | glutathione
| ACU09495.1 | −2.59 ± 0.57 |
| contig [0012] | GH987677.1 | microsomal glutathione transferase ( | ADH16761.1 | −2.19 ± 0.13 |
| ECB-C-03_D08 | GH992802.1 | cytochrome P450 monooxygenase cyp6ab4 ( | NP_001073135.1 | −2.70 ± 0.08 |
| contig [5080] | GH996933.1 | cytochrome P450 monooxygenase cyp4m5( | NP_001103833.1 | 2.81 ± 0.11 |
| J-ECB-21_A02 | GH988690.1 | aliphatic nitrilase ( | NP_001165388.1 | −2.43 ± 0.43 |
|
| ||||
| J-ECB-35_D11 | GH990122.1 | alkaline ceramidase-like isoform 1 ( | XP_003393007.1 | −3.09 ± 0.37 |
| contig [0029] | GH998728.1 | acidic lipase ( | AFI64313.1 | −2.08 ± 0.04 |
| contig [0140] | GH998810.1 | neutral lipase ( | AFI64310.1 | −4.47 ± 0.11 |
| contig [1081] | GH998825.1 | neutral lipase ( | AFI64314.1 | −2.58 ± 0.05 |
|
| ||||
| contig [1486] | GH997709.1 | C-5 sterol desaturase erg32-like ( | XP_004922936.1 | −4.96 ± 0.13 |
| contig [1897] | GH997709.1 | C-5 sterol desaturase-like ( | XP_001947459.1 | −4.48 ± 0.02 |
| J-ECB-11_B07 | GH988922.1 | fatty acid-binding protein, muscle-like isoform 2 ( | XP_001608053.1 | −2.47 ± 0.10 |
|
| ||||
| contig [4242] | GH998158.1 | alpha-amylase 2 ( | AAP97393.1 | −2.21 ± 0.03 |
| contig [4425] | GH988573.1 | enolase ( | ADO40102.1 | −2.36 ± 0.25 |
| ECB-V-12_H04 | GH995176.1 | enolase ( | AGQ53952.1 | −2.26 ± 0.02 |
| ECB-28_F02 | GH999466.1 | glucose phosphate dehydrogenase ( | ADW85328.1 | −3.05 ± 0.27 |
| contig [5232] | GH987506.1 | glycoside hydrolases ( | XP_001659854.1 | −2.31 ± 0.04 |
| contig [4123] | GH990084.1 | glucose and ribitol dehydrogenase-like ( | XP_004922759.1 | −2.28 ± 0.10 |
| ECB-V-05_G12 | GH994609.1 | UDP-glycosyltransferase UGT33J1 ( | AEW43118.1 | −2.27 ± 0.07 |
| ECB-V-08_G03 | GH994852.1 | UDP-glycosyltransferase UGT33F1 ( | AEW43115.1 | −2.25 ± 0.07 |
| ECB-12_E11 | GH998082.1 | UDP-glycosyltransferase UGT40K1 ( | AEW43171.1 | −3.62 ± 0.27 |
| ECB-V-19_F07 | GH995711.1 | glycosyltransferase 2 ( | AGG36457.1 | −2.42 ± 0.02 |
| ECB-V-22_H08 | GH995978.1 | UDP-glycosyltransferase UGT40K1 ( | AEW43171.1 | −2.80 ± 0.07 |
|
| ||||
| contig [4515] | GH987646.1 | gamma-glutamyl hydrolase A-like ( | XP_004931467.1 | −2.50 ± 0.03 |
| J-ECB-24_G10 | GH990570.1 | methyltransferase ( | CAE53466.1 | 2.14 ± 0.03 |
| contig [5690] | GH988024.1 | farnesoic acid O-methyltransferase ( | AGS17914.1 | 2.92 ± 0.07 |
| contig [1237] | GH989714.1 | farnesoic acid O-methyltransferase ( | AGS17915.1 | 2.90 ± 0.05 |
| J-ECB-30_A09 | GH987906.1 | farnesoic acid O-methyltransferase ( | AGS17914.1 | 2.91 ± 0.08 |
| contig [5679] | GH988679.1 | phosphoserine aminotransferase ( | ADO79970.1 | −2.18 ± 0.08 |
| ECB-09_B04 | GH997795.1 | asparagine synthetase ( | NP_001037414.1 | −2.38 ± 0.29 |
|
| ||||
| contig [0188] | GH997506.1 | chitinase ( | ADB85578.1 | −2.74 ± 0.23 |
| ECB-V-28_H03 | GH996480.1 | chitin synthase ( | ABB97082.1 | 2.16 ± 0.02 |
| ECB-C-05_D05 | GH992955.1 | glucosamine-fructose-6-phosphate aminotransferase 2 ( | XP_001848160.1 | −2.02 ± 0.01 |
|
| ||||
| contig [0077] | GH998660.1 | caboxypeptidase 4 ( | ACN69214.1 | −2.25 ± 0.04 |
| contig [0009] | GH992549.1 | carboxypeptidase ( | AFD99126.1 | −2.19 ± 0.05 |
| contig [0019] | GH998697.1 | plasma glutamate carboxypeptidase, partial ( | AFM38216.1 | −3.16 ± 0.19 |
| J-ECB-33_G12 | GH989302.1 | juvenile hormone epoxide hydrolase-like protein 1 ( | NP_001159617.1 | −3.00 ± 0.06 |
| contig [0557] | GH998460.1 | juvenile hormone epoxide hydrolase ( | ABD85119.1 | −2.17 ± 0.02 |
| contig [1953] | GH997798.1 | NADP-dependent oxidoreductase ( | NP_001091765.1 | −3.27 ± 0.09 |
| contig [3531] | GH995654.1 | aldo-keto reductase ( | XP_001648461.1 | −2.23 ± 0.03 |
| contig [4521] | GH989023.1 | aldo-keto reductase ( | ADQ89807.1 | −4.40 ± 0.60 |
| J-ECB-37_E05 | GH991174.1 | oxidoreductase ( | EGI66780.1 | −2.37 ± 0.05 |
| contig [4410] | GH994481.1 | methionine-R-sulfoxide reductase B1-like isoform X2 ( | XP_004924661.1 | −2.46 ± 0.03 |
| contig [3814] | GH994966.1 | alcohol dehydrogenase ( | ADM32152.1 | −2.07 ± 0.03 |
| gi_133906638 | EL929475.1 | retinol dehydrogenase 11-like (Bombyx mori) | XP_004926801.1 | −3.61 ± 0.62 |
| contig [5542] | GH997904.1 | acetyltransferase 1 ( | EHJ65205.1 | −2.98 ± 0.27 |
| J-ECB-39_F07 | GH992097.1 | cytidylate kinase ( | NP_001040356.1 | −2.73 ± 0.06 |
| BM2_M13R_B12 | GH992538.1 | estradiol 17-beta-dehydrogenase 8-like isoform X1 ( | XP_004928638.1 | −2.09 ± 0.07 |
|
| ||||
| J-ECB-60_D07 | GH987186.1 | antibacterial protein ( | ACI02333.1 | 2.84 ± 0.07 |
| gi_133905829 | EL928679.1 | hinnavin II antibacterial peptides ( | AAT94287.1 | 7.13 ± 0.22 |
| contig [2223] | GH996406.1 | peptidoglycan recognition protein C ( | ADU33186.1 | 5.04 ± 0.07 |
|
| ||||
| contig [0347] | GH987380.1 | fatty acid binding protein 1 ( | P31416.1 | 6.89 ± 0.35 |
| ECB-V-18_A08 | GH995588.1 | Fatty acid-binding protein 2 ( | EHJ79280.1 | −4.19 ± 0.32 |
| contig [0028] | GH999333.1 | cytochrome b5 ( | ADU02195.1 | −2.70 ± 0.41 |
| contig [2048] | GH994666.1 | cytochrome b561 domain-containing protein 2-like ( | XP_004933387.1 | 2.26 ± 0.03 |
| contig [4527] | GH989618.1 | cytochrome b561 domain-containing protein 1-like (Bombyx mori) | XP_004928254.1 | −7.89 ± 0.34 |
| ECB-11_E06 | GH997996.1 | peroxisomal membrane protein 11C-like ( | XP_004925254.1 | −3.51 ± 0.23 |
| gi_133907290 | EL930112.1 | interferon-induced very large GTPase 1-like ( | XP_005163746.1 | 4.37 ± 0.27 |
| contig [0566] | GH993617.1 | fatty acid binding protein ( | AEH16743.1 | −2.17 ± 0.03 |
| contig [1640] | GH991677.1 | fatty acid-binding protein, adipocyte-like ( | XP_004930401.1 | −2.99 ± 0.14 |
| contig [2896] | GH987914.1 | lipid storage droplet protein 2 ( | AEJ33049.1 | 2.28 ± 0.10 |
| contig [0407] | GH997662.1 | sensory appendage protein 3 ( | AAF16707.1 | −17.04 ± 3.80 |
| J-ECB-08_B02 | GH991953.1 | putative chemosensory protein ( | AGY49266.1 | −9.26 ± 0.49 |
| ECB-19_G03 | GH998716.1 | nose resistant to fluoxetine protein 6-like ( | XP_004929562.1 | 2.75 ± 0.01 |
| ECB-V-07_D03 | GH994735.1 | serine-rich adhesin for platelets-like ( | XP_004536543.1 | 2.66 ± 0.05 |
| contig [5724] | EL928855.1 | silk protein P25 ( | ACX50393.1 | 33.34 ± 1.92 |
| contig [4952] | GH988655.1 | fibroin light chain ( | AFS32690.1 | 53.91 ± 1.63 |
| ECB-02_H03 | GH997311.1 | saposin-like protein ( | ADU03994.1 | −2.55 ± 0.35 |
| contig [5293] | GH997917.1 | trypsin inhibitor ( | NP_001037044.1 | 90.23 ± 1.47 |
| contig [5386] | GH996141.1 | leukocyte surface antigen CD53-like isoform X5 ( | XP_004926002.1 | 2.33 ± 0.06 |
| ECB-C-04_H06 | GH992916.1 | tetraspanin D107 ( | BAD52262.1 | 2.25 ± 0.03 |
| contig [5414] | GH997359.1 | polyubiquitin-C-like isoform X1 ( | XP_005179902.1 | 2.74 ± 0.09 |
| contig [1085] | GH992931.1 | larvae cuticle protein ( | AFC88812.1 | −4.92 ± 0.36 |
| J-ECB-12_F09 | GH989631.1 | globin 1 ( | NP_001136083.1 | −2.54 ± 0.40 |
| J-ECB-29_G03 | GH992468.1 | IST1 homolog ( | XP_004931988.1 | 2.18 ± 0.07 |
| J-ECB-32_D06 | GH988574.1 | tetratricopeptide repeat protein 27-like ( | XP_004930370.1 | −2.44 ± 0.01 |
| J-ECB-47_A02 | GH990851.1 | hepatocyte growth factor-regulated tyrosine kinase substrate-like ( | XP_004932480.1 | 3.09 ± 0.62 |
|
| ||||
| gi_133905779 | EL928629.1 | pantetheinase ( | AEA76314.1 | −3.36 ± 0.13 |
| ECB-19_B09 | GH998666.1 | vanin-like protein 2-like ( | XP_004928912.1 | 2.56 ± 0.03 |
| J-ECB-14_H06 | GH990255.1 | circadian clock-controlled protein ( | EFN85083.1 | 2.27 ± 0.10 |
| ECB-V-26_F03 | GH996285.1 | Histone H3c ( | XP_001862696.1 | −2.04 ± 0.02 |
| J-ECB-07_A03 | GH991471.1 | circadian clock-controlled protein-like ( | XP_004932669.1 | 5.02 ± 0.46 |
| J-ECB-39_H09 | GH992207.1 | extracellular domains-containing protein CG31004-like isoform X2 ( | XP_004925419.1 | 2.15 ± 0.02 |
| ECB-V-25_C10 | GH996179.1 | conserved hypothetical protein ( | XP_001845252.1 | 2.29 ± 0.08 |
* The fold change and its standard errors (SE) were calculated based on five probes of the same transcript in the O. nubilalis larvae fed the artificial diet containing Cry1Ab protoxin and in the control larvae fed artificial diet without the protoxin. The symbol “−” before the fold change indicates down regulation of the transcript in the gut of O. nubilalis larvae fed on Cry1Ab protoxin. The values of the fold change in the last column are bolded if they are >10-fold.
Figure 2Validation of microarray data using RT-qPCR. Microarray (spotted bar) and RT-qPCR (outlined diamond bar) analyses of 13 differentially regulated transcripts, sequentially, including those encoding putative trypsin and trypsin-like serine protease transcripts (TLP) (EST ID: contig [4786], contig [3704], contig [0770], contig [0243], ECB-C18-B11), chymotrypsin and chymotrypsin-like serine protease transcripts (CLP) (EST ID: contig [0389], contig [1207], contig [5740]), aminopeptidase (APN) (EST ID: contig [4776], contig [4879], ECB-V05_D12), cadherin (Cad) (EST ID: J-ECB-25B09), and alkaline phosphatase (ALP) (EST ID: contig [5858]). The fold change of each transcript in the microarray (p-value < 0.05, and fold change cut off ≥2 folds) and RT-qPCR analyses (p-value ≤ 0.05) are marked on the top of each column. The symbol “*” indicates that RT-qPCR of contig [0243] did not show significant difference between the Cry1Ab protoxin and no protoxin treatments (p > 0.05).
Figure 3Microarray data quality control test using principal components analysis (PCA) plot. The blue spots indicated three samples from the larvae fed the diet with Cry1Ab protoxin, whereas the red spots represented three samples from the larvae fed the diet with on protoxin.
Sequences of primers used for reverse transcription quantitative PCR (RT-qPCR) analysis.
| Gene name | Primer sequences | Product size (bp) | EST ID |
|---|---|---|---|
| Trypsin-like serine protease | GGACAGTTCTCTGAGCAGTTAC | 109 | contig [4786] |
| ACAGCATGTTGTCAGTGATGG | |||
| Trypsin-like serine protease | ATTCTCAACAACAGGGCTATTTTG | 148 | contig [3704] |
| TGTAGTCAGGGTGGTTAATGATTC | |||
| Trypsin-like serine protease | GCATCATACCCGTCACATCTAC | 148 | contig [0770] |
| GTGAAGTTGCCGTACTGAGTC | |||
| Trypsin precursor | GCCAGCATTACACCTTCCG | 128 | contig [0243] |
| TCGCAGTTCTCGTAGTAAGAC | |||
| Silk gland derived trypsin serine protease | CACAAAGTCCTGGAGGAAGATTC | 125 | ECB-C-18-B11 |
| GTTCACGCCTGTCTGTTGC | |||
| Chymotrypsin-like serine protease | GGTGCTTGTTAGTATGTT | 116 | contig [0389] |
| AAACTTCTTTAATTGCTCAG | |||
| Chymotrypsin-like serine protease | ATAGAGCACCCGAATTACAACG | 123 | contig [1207] |
| GTAGGTTTGCGAGCCAGTG | |||
| Chymotrypsin-2 | CCCCTTCGTCCACGCTAG | 123 | contig [5740] |
| GTCACACCAACCAAGAGTCTC | |||
| Aminopeptidase N | TTCCAAACACATTTTCTTG | 118 | contig [4776] |
| AAGCGTATTGTCCTCTAT | |||
| Aminopeptidase N | CAGTAGCGATAACATCAC | 183 | contig [4879] |
| CCAGTCAAGTCTTCTCTA | |||
| Aminopeptidase N | GTCAACGAAATTGTCATC | 109 | ECB-V-05-D12 |
| AGTCATATTCTGGCTGTA | |||
| Cadherin-like protein | CTATGTGTTCTCAATCCAA | 75 | J-ECB-25-B09 |
| TCGTCGATGTTGACTATC | |||
| Alkaline phosphatase | CGGATTATCTGCTGGGTTTATTTG | 79 | contig [5858] |
| AGTGTGGGCTCGGTAACG |